Posted in | News

Sharda Glass Licenses Use DuPont SentryGlas Expressions for Decorative Glass in the United Kingdom

DuPont Glass Laminating Solutions has licensed its DuPont™ SentryGlas® Expressions™ digital interlayer technology to Sharda Glass, Ltd. located in West Drayton, United Kingdom. Established in 2006 by Neil Sharda, Sharda Glass is a UK-based company specializing in the production of high performance structural and architectural glass products.

The agreement allows Sharda Glass to produce and distribute high-definition, decorative laminated safety glass to meet growing demand for custom designed imagery and aesthetics in laminated glass.

Sharda Glass, Ltd. was chosen by DuPont Glass Laminating Solutions to help expand the use of SentryGlas® Expressions™ through its decorative market access and its reputation for high-quality laminating. Both the printing and the lamination of the polyvinyl butyral (PVB) decorative interlayers will be done in their West Drayton facility, providing a faster, efficient response to customer needs.

Sharda Glass, Ltd. is the first licensee in the United Kingdom offering SentryGlas® Expressions™; they are accepting commercial project orders immediately.

"In response to growing demand for innovative ways to combine safety and aesthetics in buildings, we are licensing trusted, quality oriented partners to provide our decorative interlayer technology to architects, designers, builders and contractors," said Valerie A. Aunet, Global Marketing Manager for DuPont™ SentryGlas® Expressions™. "By increasing our collaboration and cooperation with important customers, such as Sharda Glass, we can continue to deliver the high-quality imagery and design textures of SentryGlas® Expressions™ to unique projects around the world."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.